This is a delivery order issued under a federal contract awarded to Lovelace Biomedical Research Institute, a not-for-profit preclinical contract research organization. The contract, with a ceiling value of $140,848.00, is for the evaluation of a potential respiratory stimulant for the treatment of drug-induced respiratory depression and overdose toxicity. The work is being performed for the National Institute on Drug Abuse, a civilian agency within the Department of Health and Human Services. This contract is not set aside. Lovelace Biomedical Research Institute has extensive experience supporting federal agencies like the NIH, DoD, and HHS with a wide range of preclinical research services, including animal studies, analytical testing, and product manufacturing.
Generated 3/12/25, 9:54 AM